Iris Pharma is dedicated to ocular pharmacokinetic studies

Iris Pharma is a French Contract Research Organization (CRO) dedicated to preclinical research, ocular drug development, ocular services and pharmacokinetic studies in ophthalmology.

Founded in 1989 by Pierre-Paul Elena, Ph.D., Iris Pharma provides drug development pharmacokinetic studies to Biotechnology and Pharmaceutical Industries.

In-depth pharmacokinetic studies

In animal, Iris Pharma performs pharmacokinetic studies of ocular drug and metabolite. Pharmacokinetic studies - formulation: eye drop, eye gel, ointment, insert, implant, patch, cream

Pharmacokinetic studies - administration: topical ocular application, subconjunctival injection, subtenon injection, retrobulbar injection, periocular injection, intracameral injection, intravitreal injection.

Pharmacokinetic studies - detection: non radioactive or radioactive.

In Healthy Volunteers (phase I clinical study) Iris Pharma has the capabilities to perform the following types of phase 1 clinical studies: Ocular Tolerance, Safety, Systemic and Ocular Pharmacokinetics - pharmacodynamics (PK/PD) and first administration in human.

Analytical testing laboratory and pharmacokinetic studies

Iris Pharma's Bioanalytical testing Department never stops analyzing in our GLP compliant laboratory: preclinical and clinical pharmacokinetic studies and others sample analyses.